Development of a specialised reproductive rheumatology consultation service: analysis of referral patterns across preconception, pregnancy, and lactation
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Women with inflammatory rheumatic and musculoskeletal disease (iRMD) face unique challenges during preconception, pregnancy, and lactation. In 2024, a specialised consultation service was developed and implemented at the tertiary rheumatology centre of the Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany, to address these specific needs. METHODS: Demographic characteristics, disease- and treatment-related data, reproductive status, referring physician, reasons for consultation, and recommendations for disease management were collected between 1 January 2024 and 3 April 2025. RESULTS: Overall, 57 patients were included; the mean age was 33.3 ± 4.4 years and the mean disease duration was 6.3 ± 4.8 years. Almost all patients (94.7%) had a confirmed diagnosis of an iRMD. 57.9% were planning a pregnancy, 40.4% were pregnant, and 1.8% were breastfeeding. At baseline, 21.8% were receiving csDMARDs and 50.9% were receiving bDMARDs. Glucocorticoid use was documented in 16.1%. Patients were referred by rheumatologists (35.7%), the in-house outpatient clinic (37.5%), general practitioners (14.3%), gynaecologists (10.7%), and the in-house inpatient clinic (1.8%). The most frequent reasons for consultation were patient concerns regarding pregnancy and medication safety. Consultation reasons differed descriptively between patients in the preconception period and pregnant patients; however, these exploratory differences should be interpreted with caution. Recommendations made during consultation included modification of DMARD therapy (35.1%), initiation of fetal bradycardia screening (19.3%), and preeclampsia prophylaxis (8.8%). CONCLUSION: A dedicated reproductive rheumatology consultation service provides structured support for women with iRMDs throughout preconception, pregnancy, and lactation. Medication adjustments and targeted preventive measures were recommended for more than one-third of patients, highlighting the potential value of preconception referral and specialized reproductive rheumatology consultation. CLINICAL TRIAL NUMBER: Not applicable.
Source: BMC Rheumatology
Authors: Diana Vossen(Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft), Anna Kernder, Daniela Odehnal, David Kiefer(Writing – review & editing), Ioana Andreica(Writing – review & editing), Johanna Mucke(Writing – review & editing), Sungyoung Chung(Data curation), Dennis Brosch, Styliani Tsiami(Data curation, Writing – review & editing), Philipp Sewerin(Conceptualization, Supervision, Writing – review & editing), Xenofon Baraliakos(Conceptualization, Supervision, Writing – review & editing), Uta Kiltz(Conceptualization, Methodology, Project administration, Supervision, Writing – review & editing)
Institutions: Rheumazentrum Ruhrgebiet, Ruhr University Bochum
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,190
Funder: Ruhr-Universität Bochum
OpenAlex ID: W7163707406
